482 related articles for article (PubMed ID: 34193870)
21. Immune Response to SARS-CoV-2 Vaccine in 2 Men.
Gupta S; Su H; Agrawal S
Int Arch Allergy Immunol; 2022; 183(3):350-359. PubMed ID: 34794147
[TBL] [Abstract][Full Text] [Related]
22. Mild Cytokine Elevation, Moderate CD4
Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response.
Turner JS; Day A; Alsoussi WB; Liu Z; O'Halloran JA; Presti RM; Patterson BK; Whelan SPJ; Ellebedy AH; Mudd PA
Front Immunol; 2020; 11():618402. PubMed ID: 33488630
[TBL] [Abstract][Full Text] [Related]
24. Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection.
Hou H; Zhang Y; Tang G; Luo Y; Liu W; Cheng C; Jiang Y; Xiong Z; Wu S; Sun Z; Xu S; Fan X; Wang F
J Allergy Clin Immunol; 2021 Dec; 148(6):1481-1492.e2. PubMed ID: 34536418
[TBL] [Abstract][Full Text] [Related]
25. Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection.
Yang G; Cao J; Qin J; Mei X; Deng S; Xia Y; Zhao J; Wang J; Luan T; Chen D; Huang P; Chen C; Sun X; Luo Q; Su J; Zhang Y; Zhong N; Wang Z
Signal Transduct Target Ther; 2024 May; 9(1):141. PubMed ID: 38811527
[TBL] [Abstract][Full Text] [Related]
26. Clinical and immunological characteristics in COVID-19 convalescent patients.
Su Z; Hu W; Liu Q; Zhang Y; Chen T; Zhou Y; Zhang Z; Chen Y; Yang R; Xiong Y; Wang X
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2669-2676. PubMed ID: 34625887
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
[TBL] [Abstract][Full Text] [Related]
28. Repurposing CD8
Gujar S; Pol JG; Kim Y; Kroemer G
Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
[TBL] [Abstract][Full Text] [Related]
29. Characterization of pre-existing and induced SARS-CoV-2-specific CD8
Schulien I; Kemming J; Oberhardt V; Wild K; Seidel LM; Killmer S; Sagar ; Daul F; Salvat Lago M; Decker A; Luxenburger H; Binder B; Bettinger D; Sogukpinar O; Rieg S; Panning M; Huzly D; Schwemmle M; Kochs G; Waller CF; Nieters A; Duerschmied D; Emmerich F; Mei HE; Schulz AR; Llewellyn-Lacey S; Price DA; Boettler T; Bengsch B; Thimme R; Hofmann M; Neumann-Haefelin C
Nat Med; 2021 Jan; 27(1):78-85. PubMed ID: 33184509
[TBL] [Abstract][Full Text] [Related]
30. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
[TBL] [Abstract][Full Text] [Related]
31. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
[TBL] [Abstract][Full Text] [Related]
32. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4
Pušnik J; Richter E; Schulte B; Dolscheid-Pommerich R; Bode C; Putensen C; Hartmann G; Alter G; Streeck H
Cell Rep; 2021 Jun; 35(13):109320. PubMed ID: 34146478
[TBL] [Abstract][Full Text] [Related]
33. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
Cromer D; Juno JA; Khoury D; Reynaldi A; Wheatley AK; Kent SJ; Davenport MP
Nat Rev Immunol; 2021 Jun; 21(6):395-404. PubMed ID: 33927374
[TBL] [Abstract][Full Text] [Related]
34. BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype.
Guerrera G; Picozza M; D'Orso S; Placido R; Pirronello M; Verdiani A; Termine A; Fabrizio C; Giannessi F; Sambucci M; Balice MP; Caltagirone C; Salvia A; Rossini A; Battistini L; Borsellino G
Sci Immunol; 2021 Dec; 6(66):eabl5344. PubMed ID: 34726470
[TBL] [Abstract][Full Text] [Related]
35. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
Roukens AHE; Pothast CR; König M; Huisman W; Dalebout T; Tak T; Azimi S; Kruize Y; Hagedoorn RS; Zlei M; Staal FJT; de Bie FJ; van Dongen JJM; Arbous SM; Zhang JLH; Verheij M; Prins C; van der Does AM; Hiemstra PS; de Vries JJC; Janse JJ; Roestenberg M; Myeni SK; Kikkert M; Yazdanbakhsh M; Heemskerk MHM; Smits HH; Jochems SP; ;
Nat Immunol; 2022 Jan; 23(1):23-32. PubMed ID: 34937933
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.
Kared H; Redd AD; Bloch EM; Bonny TS; Sumatoh H; Kairi F; Carbajo D; Abel B; Newell EW; Bettinotti MP; Benner SE; Patel EU; Littlefield K; Laeyendecker O; Shoham S; Sullivan D; Casadevall A; Pekosz A; Nardin A; Fehlings M; Tobian AA; Quinn TC
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33427749
[TBL] [Abstract][Full Text] [Related]
37. Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology.
Khanolkar A
Cells; 2021 Dec; 11(1):. PubMed ID: 35011627
[TBL] [Abstract][Full Text] [Related]
38. Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19.
Kumar S; Saxena SK; Maurya VK; Tripathi AK
Front Immunol; 2021; 12():804808. PubMed ID: 35250966
[TBL] [Abstract][Full Text] [Related]
39. Endemic SARS-CoV-2 will maintain post-pandemic immunity.
Veldhoen M; Simas JP
Nat Rev Immunol; 2021 Mar; 21(3):131-132. PubMed ID: 33402727
[TBL] [Abstract][Full Text] [Related]
40. Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020).
Kim DS; Rowland-Jones S; Gea-Mallorquí E
Front Immunol; 2020; 11():571481. PubMed ID: 33362759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
